Table 2.
Summary of quantitative data analysis.
| Indexes | Pooled data | Groups | Participants | Random effects SMD (95% CI) | I2 (%) | P for heterogeneity |
|---|---|---|---|---|---|---|
| Superoxide dismutase | vs. model group | 9 | 211 | 1.57 (1.16, 1.98) | 94.90% | P < 0.05 |
| vs. Western medicine group | 8 | 191 | 0.56 (0.19, 0.92) | 94.50% | P < 0.05 | |
| Malonicaldehyde | vs. model group | 9 | 211 | −1.5 (1.88, −1.17) | 91.10% | P < 0.05 |
| vs. Western medicine group | 8 | 191 | −0.64 (−0.95, −0.33) | 83.60% | P < 0.05 | |
| Glutathione peroxidase | vs. model group | 3 | 50 | 6.13 (4.74, 7.6) | 51.40% | P = 0.128 |
| vs. Western medicine group | 2 | 30 | 1.46 (0.62, 2.29) | 38.30% | P = 0.203 | |
| Glucose | vs. model group | 3 | 59 | −0.73 (−1.27, −0.19) | 54% | P = 0.114 |
| vs. Western medicine group | 2 | 38 | 1.123 (0.374, 1.873) | 90.80% | P < 0.05 | |
| Serumcreatinine | vs. model group | 4 | 77 | −1.404 (−1.953, −0.856) | 86.20% | P < 0.05 |
| vs. Western medicine group | 3 | 56 | 0.471 (−0.061, 1.003) | 0.00% | P = 0.983 | |
| Blood urea nitrogen | vs. model group | 5 | 93 | −2.026 (−2.569, −1.483) | 79.90% | P < 0.05 |
| vs. Western medicine group | 4 | 72 | −0.247 (−0.753, 0.260) | 85.20% | P < 0.05 | |
| Urinary protein excretion | vs. model group | 2 | 31 | −1.370 (−2.255, −0.486) | 90.50% | P < 0.05 |
| vs. Western medicine group | 2 | 30 | −0.245 (−0.966, 0.476) | 0% | P = 0.552 |